154 related articles for article (PubMed ID: 31021852)
1. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women.
Murnane PM; Bacchetti P; Currier JS; Brummel S; Okochi H; Phung N; Louie A; Kuncze K; Hoffman RM; Nematadzira T; Soko DK; Owor M; Saidi F; Flynn PM; Fowler MG; Gandhi M
AIDS; 2019 Aug; 33(10):1657-1662. PubMed ID: 31021852
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair.
Nematadzira TG; Murnane PM; Odiase OJ; Bacchetti P; Okochi H; Tallerico R; Chanaiwa VM; Vhembo T; Mutambanengwe-Jacob MT; Louie A; Chipato T; Gandhi M; Stranix-Chibanda L;
J Acquir Immune Defic Syndr; 2022 Nov; 91(3):237-241. PubMed ID: 35952357
[TBL] [Abstract][Full Text] [Related]
3. Detectable HIV RNA in late pregnancy associated with low tenofovir hair levels at time of delivery among women living with HIV in the United States.
Pintye J; Huo Y; Kacanek D; Zhang K; Kuncze K; Okochi H; Gandhi M;
AIDS; 2021 Feb; 35(2):267-274. PubMed ID: 33055571
[TBL] [Abstract][Full Text] [Related]
4. Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women.
Koss CA; Natureeba P; Mwesigwa J; Cohan D; Nzarubara B; Bacchetti P; Horng H; Clark TD; Plenty A; Ruel TD; Achan J; Charlebois ED; Kamya MR; Havlir DV; Gandhi M
AIDS; 2015 Apr; 29(7):825-30. PubMed ID: 25985404
[TBL] [Abstract][Full Text] [Related]
5. Use of Tenofovir Diphosphate Levels to Predict Viremia During the Postpartum Period in Women Living With Human Immunodeficiency Virus (HIV): A Nested Case-Control Study.
Odayar J; Orrell C; Phillips TK; Hu NC; Kabanda S; Malaba TR; Allerton J; Wiesner L; Hsiao NY; Castillo-Mancilla J; Lesosky M; Myer L
Clin Infect Dis; 2022 Sep; 75(5):761-767. PubMed ID: 34979553
[TBL] [Abstract][Full Text] [Related]
6. Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children.
Himes SK; Wu JW; Jacobson DL; Tassiopoulos K; Hazra R; Kacanek D; Van Dyke RB; Rich KC; Siberry GK; Huestis MA;
Pediatr Infect Dis J; 2015 Aug; 34(8):851-7. PubMed ID: 25961889
[TBL] [Abstract][Full Text] [Related]
7. Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination.
Thaden JT; Gandhi M; Okochi H; Hurt CB; McKellar MS
AIDS; 2018 Jun; 32(9):F1-F4. PubMed ID: 29683856
[TBL] [Abstract][Full Text] [Related]
8. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.
Gandhi M; Ameli N; Bacchetti P; Anastos K; Gange SJ; Minkoff H; Young M; Milam J; Cohen MH; Sharp GB; Huang Y; Greenblatt RM
Clin Infect Dis; 2011 May; 52(10):1267-75. PubMed ID: 21507924
[TBL] [Abstract][Full Text] [Related]
9. Stable Caloric Intake and Continued Virologic Suppression for HIV-Positive Antiretroviral Treatment-Experienced Women After Switching to a Single-Tablet Regimen of Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate.
Menezes P; Mollan K; Hoffman E; Xie Z; Wills J; Marcus C; Rublein J; Hudgens M; Eron JJ
AIDS Res Hum Retroviruses; 2018 Jun; 34(6):481-485. PubMed ID: 29607652
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
Tabb ZJ; Mmbaga BT; Gandhi M; Louie A; Kuncze K; Okochi H; Shayo AM; Turner EL; Cunningham CK; Dow DE
AIDS; 2018 Jun; 32(9):1115-1123. PubMed ID: 29438196
[TBL] [Abstract][Full Text] [Related]
11. Short Communication: Higher Tenofovir Concentrations in Hair Are Associated with Decreases in Viral Load and Not Self-Reported Adherence in HIV-Infected Adolescents with Second-Line Virological Treatment Failure.
Chawana T; Nhachi C; Nathoo K; Ngara B; Okochi H; Louie A; Kuncze K; Katzenstein D; Metcalfe J; Gandhi M
AIDS Res Hum Retroviruses; 2021 Oct; 37(10):748-750. PubMed ID: 33499754
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first-line therapy in South Africa: a case-control cohort study.
Castillo-Mancilla JR; Edwards JA; Brijkumar J; Moosa MY; Zhao Y; Ofotokun I; Johnson BA; Lee MH; Pillay S; Pillay M; Moodley P; Kuritzkes DR; Sunpath H; Bushman LR; Ellison L; Anderson PL; Marconi VC
J Int AIDS Soc; 2021 Dec; 24(12):e25849. PubMed ID: 34910844
[TBL] [Abstract][Full Text] [Related]
13. Extent of In Utero Transfer of Tenofovir From Mother to Fetus: A Paired Analysis of Hair Specimens Collected at Birth From a Cohort in the United States.
Pintye J; Huo Y; Kacanek D; Zhang K; Kuncze K; Okochi H; Gandhi M
J Infect Dis; 2021 Feb; 223(4):638-644. PubMed ID: 32620015
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa.
Singh Y; Castillo-Mancilla J; Madimabe R; Jennings L; Ferraris CM; Robbins RN; Anderson PL; Remien RH; Orrell C
AIDS Res Ther; 2023 Sep; 20(1):67. PubMed ID: 37705102
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Plasma Efavirenz and Tenofovir, Dried Blood Spot Tenofovir-Diphosphate, and Self-Reported Adherence to Predict Virologic Suppression Among South African Women.
Phillips TK; Sinxadi P; Abrams EJ; Zerbe A; Orrell C; Hu NC; Brittain K; Gomba Y; Norman J; Wiesner L; Myer L; Maartens G
J Acquir Immune Defic Syndr; 2019 Jul; 81(3):311-318. PubMed ID: 30893125
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.
Murewanhema G; Malisheni M; Takah NF
Pan Afr Med J; 2021; 38():308. PubMed ID: 34178226
[TBL] [Abstract][Full Text] [Related]
17. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.
Ngarina M; Kilewo C; Karlsson K; Aboud S; Karlsson A; Marrone G; Leyna G; Ekström AM; Biberfeld G
BMC Infect Dis; 2015 Apr; 15():175. PubMed ID: 25886277
[TBL] [Abstract][Full Text] [Related]
18. Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa.
Stranix-Chibanda L; Anderson PL; Kacanek D; Hosek S; Huang S; Nematadzira TG; Taulo F; Korutaro V; Nakabiito C; Masenya M; Lypen K; Brown E; Ibrahim ME; Yager J; Wiesner L; Johnston B; Amico KR; Rooney JF; Chakhtoura N; Spiegel HML; Chi BH;
Clin Infect Dis; 2021 Oct; 73(7):e1893-e1900. PubMed ID: 33341883
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China.
Yan J; Liu J; Su B; Pan X; Wang Z; Wu J; Zhang J; Ruan Y; Hsi J; Liao L; Shao Y; Xing H
PLoS One; 2016; 11(4):e0154421. PubMed ID: 27119346
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy.
Pintye J; Bacchetti P; Teeraananchai S; Kerr S; Prasitsuebsai W; Singtoroj T; Kuncze K; Louie A; Koss CA; Jin C; Phung N; Horng H; Sohn AH; Gandhi M
J Acquir Immune Defic Syndr; 2017 Dec; 76(4):367-371. PubMed ID: 28825944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
